Efficacy and safety of secukinumab in treating moderate to severe plaque psoriasis in two real‐world Canadian dermatology clinics: a multicenter retrospective study
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.14468
Abstract: diomyopathy during therapy with dabrafenib and trametinib. When myocarditis was first reported during treatment with dabrafenib and trametinib, a warning was published by the European Medicine Agency and myocarditis added to the serious side-effects. Differential… read more here.
Keywords: dermatology; efficacy safety; secukinumab treating; moderate severe ... See more keywords